Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol

BACKGROUND: The optimal duration of anticoagulation after a first unprovoked venous thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant therapy indefinitely after completing 3 to 6 months of initial treatment requires balancing the long-term risk of recurrent VTE...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Faizan, Kimpton, Miriam, Tritschler, Tobias, Le Gal, Grégoire, Hutton, Brian, Fergusson, Dean A., Rodger, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819358/
https://www.ncbi.nlm.nih.gov/pubmed/31661033
http://dx.doi.org/10.1186/s13643-019-1175-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819358/
https://www.ncbi.nlm.nih.gov/pubmed/31661033
http://dx.doi.org/10.1186/s13643-019-1175-5

Ejemplares similares